Halotestin vs Anadrol: complete comparison (extreme orals, strength vs mass)

Key takeaways

  • ●Halotestin (ratio 1900:850) explodes strength without mass (no retention), marked aggression, extreme hepatotoxicity.
  • ●Anadrol (320:45) explodes mass with massive retention, indirect estrogenic effects, extreme hepatotoxicity.
  • ●Both are highly toxic 17α-alkylated drugs, reserved for advanced competitors on 3-4 weeks maximum.
  • ●Halotestin = strongman/powerlifting (pre-competition strength). Anadrol = bodybuilding (extreme mass kickstart).
Critèrehalotestinanadrol
Anabolic/androgenic ratio1900:850320:45
Half-life~9 h~9 h
Main effectStrength and aggressionMass and retention
Water retentionMinimalVery marked
HepatotoxicityExtreme (17α-alkylated)Very high (17α-alkylated)
Typical dose10-20 mg/d50-100 mg/d
Max duration2-4 weeks3-4 weeks
Target userPowerlifters / StrongmenAdvanced bodybuilders

Quand choisir halotestin

Halotestin (fluoxymesterone) is the most androgenic oral in the AAS landscape, with an extreme ratio 1900:850 (Hudson 1959, Saartok 1984). Choose it only for: (1) a strength competition or strongman where the strength peak a few hours before the session matters (marked psycho-stimulant and neuromuscular effect from D3-D5), (2) a competitive bodybuilding finish where you want to add visual hardness and training aggression without stacking mass. Halotestin does not cause visible muscle mass gains at pharmacological doses (its gains/dose curve plateaus quickly due to lack of raw anabolic effect despite high theoretical ratio). Its interest is purely psycho-behavioral and neurological: increased aggression, focus, sense of power, and a spectacular 'pump' effect in the gym. Toxicity profile among the most severe (Niedfeldt 2018, Kicman 2008): extreme hepatotoxicity (cases of cholestatic hepatitis documented at 20 mg/d × 4 weeks), catastrophic lipid profile (HDL crashed, LDL up), marked psychiatric effects (aggression, paranoia). Typical dose 10-20 mg/d × 2-4 weeks maximum in pre-competition. Never without testosterone base, never in long cycle, tight ALT/AST/bilirubin monitoring.

Quand choisir anadrol

Anadrol (oxymetholone) is the most potent oral in terms of raw mass. Hengge 2003 documented +8.2 kg of lean mass in 16 weeks at 150 mg/d in HIV-wasting patients — the highest amplitude ever reported for an oral AAS. Choose it for: (1) a maximum kickstart over 3-4 weeks before a long ester takes over, (2) breaking through a plateau mid-cycle, (3) an offseason cycle in an experienced competitor seeking rapid gains. Reserved for advanced users (Niedfeldt 2018, Pope 2014): very high hepatotoxic profile (cases of intrahepatic cholestasis and hepatic peliosis documented at 100 mg/d × 8 weeks), indirect estrogenic effects via direct interaction with muscular and mammary estrogen receptor — gynecomastia can appear without elevated estradiol, and an AI alone is ineffective. Gyno control goes through SERM (nolvadex 20-40 mg/d in parallel). Sometimes unmanageable BP, psychological effects (irritability, aggression, post-cycle anhedonia) in ~30% of users. Typical dose 50-75 mg/d × 3-4 weeks maximum, with minimum 8-week hepatic break.

Combinaison ?

The halotestin + anadrol combo is extremely inadvisable: two 17α-alkylated drugs with hepatic toxicity among the highest, stacking loads without additive anabolic benefit and with major cardiovascular and psychiatric cumulative effect. If you want both effects (pure strength and mass), structure in sequence on different cycles: an offseason mass cycle with anadrol kickstart (50 mg/d × 3 weeks), then 8 weeks off-oral, then a competitive strength window with halotestin (10-20 mg/d × 2 weeks pre-competition). Always on strong testosterone base (500 mg/week) to ensure androgenic role. Mandatory monitoring: ALT, AST, GGT, bilirubin, lipids, BP, creatinine at W0 then every week during oral block. Hepatoprotectors (TUDCA 500 mg, NAC 1200 mg). No hepatologist would recommend this sequence — it is an assumed risk in competition. Sample sequential approach for compound competitor: offseason cycle W1-W3 anadrol 50 mg/d as kickstart, W4-W10 testo + traditional compounds, W11 last testo injection, W14 PCT start, W22 post-PCT, then 6 months off-oral hepatic recovery. Competitive strength prep: meet day 1 only with halotestin 20 mg pre-warmup, repeat for max attempts only if needed (1-2 days total), then immediate stop. Combined annual hepatic exposure should stay under 6 weeks of any 17α-alkylated compound. Practical psychological consideration: halotestin aggression effect can affect interpersonal relationships and decision-making — competitor must communicate with training partners, family, coach to manage behavioral changes during the 1-3 day use window. Sample baseline panel must include CBC, comprehensive metabolic panel, lipids with apoB, ALT/AST/GGT, total and direct bilirubin, T total, E2, creatinine, fasting glucose, and resting BP averaged over three days. Hepatology consultation recommended before any halotestin or anadrol use due to exceptionally high hepatic load specific to these two compounds.

FAQ

Halotestin or anadrol for pure strength?
Halotestin, without hesitation. Oxymetholone certainly increases strength via added muscle volume and retention, but halotestin offers a much sharper neurological and neuromuscular strength jump, without added mass — exactly what a powerlifter or strongman seeks for a weight category competition. The effect is felt in a few days, peak at W2, and allows beating PRs with a 5-10% gain on maximum loads. Anadrol takes weeks to deliver its mass potential.
Why is halotestin so hepatotoxic?
Three cumulative factors (Niedfeldt 2018, Kicman 2008): (1) 17α-alkylated modification with unfavorable hepatic profile, (2) fluorine atom at 9α position that adds specific metabolic toxicity, (3) pharmacological doses needed for effect (20-40 mg/d) rapidly saturate hepatic detoxification pathways. Documented cases of cholestatic hepatitis and hepatic peliosis at therapeutic doses lower than those used in bodybuilding. The FDA has strongly restricted its clinical use to very specific indications (breast cancer, refractory aplastic anemia).
What monitoring under halotestin?
Complete panel before cycle (W0): ALT, AST, GGT, total and direct bilirubin, CBC, lipids, creatinine, BP. Weekly hepatic panel throughout cycle. Immediate stop if ALT > 3× normal or elevated direct bilirubin. Weekly home BP. Subjective monitoring of psychiatric effects (paranoid aggression, sleep disorders, mood swings). Any sign should lead to early stop — no progressive tolerance under halotestin.
Does anadrol really give +8 kg in 4 weeks?
Possible but variable. Hengge 2003 measured +8.2 kg over 16 weeks at 150 mg/d in HIV cachexia patients. In a bodybuilder user at 50 mg/d × 4 weeks as kickstart of a testo cycle, the realistic amplitude is +5 to +8 kg raw mass, of which 40-60% water retention and glycogen leaving on cessation. Net muscular gains retained at 3 months post-PCT: +2 to +4 kg attributable to anadrol alone. More marked effect in lean users; saturation in already advanced users.
Are there less toxic alternatives?
For strength: trenbolone or even testosterone + creatine offer significant strength jump with much lower toxicity than halotestin — without however reproducing the acute psycho-stimulant effect. For mass kickstart: dianabol 25-30 mg/d × 4-6 weeks offers 70% of anadrol effect with more tolerable hepatic and cardiovascular profile. Reasonable users avoid halotestin and anadrol in favor of better risk/benefit ratio molecules.
What PCT after a halotestin or anadrol cycle?
Standard scheme. Start 3-4 days after last oral intake (half-life ~9 h). hCG 1500 IU EOD × 7 days to restart atrophied testicles (useful because both strongly suppress HPG axis in a few days), then clomid 50/50/25/25 mg × 4-6 weeks + nolvadex 20/20/10/10 mg to prevent estrogenic rebounds (essential after anadrol which sensitizes breast tissue). Complete panel at W6 post-PCT.
Is halotestin suitable for D-day preworkout?
Widespread practice in strength competition: 10-20 mg taken 30-60 minutes before the session to benefit from the neurological peak and psycho-stimulant effect. Several powerlifting/strongman athletes use it only on competition days (ultra-short cycle 1-3 days). At this occasional posology, hepatic toxicity remains limited but the strength effect is marked. Do not exceed 3 consecutive days at 20 mg, and keep 8-12 week interval between two major competitions to avoid cumulative exposure.
Can anadrol also have an effect on pure strength?
Yes, but via a different mechanism: glycogen and intramuscular water retention increases strength by volumetric effect (favorable levers, hydraulic lever of inflated muscle). Strength increase under anadrol is generally +5-10% on bench press in 3-4 weeks, but partially disappears on cessation with loss of retention. It is less 'clean' than halotestin's neurological effect and more dependent on added mass.